Fact Based List:

GAO: Five Highest Expenditure New Medicare Part B Drugs, 2013 (Total Expenditures in Millions)

  1. Lucentis - $1,369
  2. Eylea - $1,088
  3. Prolia - $665
  4. Treanda - $332
  5. Lexiscan - $257

Source: U.S. Government Accountability Office
Source URL: http://www.gao.gov/products/GAO-16-12